Compare Stocks: ORINY, OTSKY, TEVA, and SDZNY

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ORINY Orion OYJ	$43.02	$40.41	$30.89 ▼ $43.22	$12.14B	0.07	61 shs	28 shs
OTSKY Otsuka	$37.62 -3.6%	$34.80	$25.30 ▼ $40.92	$41.94B	-0.04	35,743 shs	34,597 shs
SDZNY Sandoz Group	$89.81 -0.9%	$84.51	$55.42 ▼ $94.15	$39.89B	0.58	26,291 shs	11,537 shs
TEVA Teva Pharmaceutical Industries	$36.79 +0.7%	$33.52	$17.33 ▼ $37.39	$42.56B	0.86	5.94 million shs	2.33 million shs

7 Stocks That Could Lead the Next Market Boom

Tesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ORINY Orion OYJ	0.00%	0.00%	+11.61%	+13.24%	+11.93%
OTSKY Otsuka	+1.00%	+1.57%	+14.37%	+10.20%	+44.10%
SDZNY Sandoz Group	+1.56%	+6.48%	+13.08%	+9.06%	+52.70%
TEVA Teva Pharmaceutical Industries	-0.88%	+5.06%	+14.85%	+6.50%	+112.18%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ORINY Orion OYJ	$43.02	$40.41	$30.89 ▼ $43.22	$12.14B	0.07	61 shs	28 shs
OTSKY Otsuka	$37.62 -3.6%	$34.80	$25.30 ▼ $40.92	$41.94B	-0.04	35,743 shs	34,597 shs
SDZNY Sandoz Group	$89.81 -0.9%	$84.51	$55.42 ▼ $94.15	$39.89B	0.58	26,291 shs	11,537 shs
TEVA Teva Pharmaceutical Industries	$36.79 +0.7%	$33.52	$17.33 ▼ $37.39	$42.56B	0.86	5.94 million shs	2.33 million shs

7 Stocks That Could Lead the Next Market Boom

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ORINY Orion OYJ	0.00%	0.00%	+11.61%	+13.24%	+11.93%
OTSKY Otsuka	+1.00%	+1.57%	+14.37%	+10.20%	+44.10%
SDZNY Sandoz Group	+1.56%	+6.48%	+13.08%	+9.06%	+52.70%
TEVA Teva Pharmaceutical Industries	-0.88%	+5.06%	+14.85%	+6.50%	+112.18%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
ORINY Orion OYJ	2.33	Hold	N/A	N/A
OTSKY Otsuka	2.00	Hold	N/A	N/A
SDZNY Sandoz Group	3.50	Strong Buy	N/A	N/A
TEVA Teva Pharmaceutical Industries	2.90	Moderate Buy	$42.22	14.78% Upside

Current Analyst Ratings Breakdown

Latest ORINY, OTSKY, TEVA, and SDZNY Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
8/12/2026	TEVA Teva Pharmaceutical Industries	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Overweight	$40.00 ➝ $42.00
7/31/2026	TEVA Teva Pharmaceutical Industries	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (D-) ➝ Hold (C-)
7/28/2026	TEVA Teva Pharmaceutical Industries	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Overweight	$42.00 ➝ $44.00
7/17/2026	TEVA Teva Pharmaceutical Industries	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (D-)

(Data available from 8/14/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
ORINY Orion OYJ	$2.14B	5.68	$2.23 per share	19.27	$5.23 per share	8.22
OTSKY Otsuka	$16.51B	2.45	$2.88 per share	13.08	$19.33 per share	1.95
SDZNY Sandoz Group	$11.09B	3.56	$3.58 per share	25.10	$21.33 per share	4.21
TEVA Teva Pharmaceutical Industries	$17.26B	2.48	$3.76 per share	9.79	$6.66 per share	5.52

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
ORINY Orion OYJ	$566.04M	$2.43	17.70	N/A	N/A	28.52%	50.37%	30.65%	N/A
OTSKY Otsuka	$2.43B	$2.49	15.11	17.10	7.38	15.50%	12.93%	9.55%	10/30/2026 (Estimated)
SDZNY Sandoz Group	$914M	N/A	N/A	19.27	1.90	N/A	N/A	N/A	N/A
TEVA Teva Pharmaceutical Industries	$1.41B	$0.60	61.31	12.14	3.91	4.08%	32.64%	6.34%	N/A

Latest ORINY, OTSKY, TEVA, and SDZNY Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
7/31/2026	Q2 2026	OTSKY Otsuka	$0.5060	$0.70	+$0.1940	$0.70	$3.95 billion	$4.41 billion
7/29/2026	Q2 2026	TEVA Teva Pharmaceutical Industries	$0.08	$0.02	-$0.06	-$0.49	$4.02 billion	$4.14 billion
7/17/2026	Q2 2026	ORINY Orion OYJ	N/A	$0.58	N/A	$0.58	N/A	$606.38 million
6/30/2026	Q2 2026	TEVA Teva Pharmaceutical Industries	N/A	$0.02	N/A	-$0.49	N/A	$4.14 billion

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
ORINY Orion OYJ	$0.38	0.88%	N/A	15.64%	N/A
OTSKY Otsuka	$0.26	0.69%	N/A	10.44%	N/A
SDZNY Sandoz Group	$0.61	0.68%	N/A	N/A	N/A
TEVA Teva Pharmaceutical Industries	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
ORINY Orion OYJ	0.08	2.64	1.48
OTSKY Otsuka	0.05	2.17	1.67
SDZNY Sandoz Group	0.53	1.18	0.77
TEVA Teva Pharmaceutical Industries	1.56	0.88	0.67

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
ORINY Orion OYJ	N/A
OTSKY Otsuka	N/A
SDZNY Sandoz Group	0.05%
TEVA Teva Pharmaceutical Industries	54.05%

Insider Ownership

Company	Insider Ownership
ORINY Orion OYJ	N/A
OTSKY Otsuka	N/A
SDZNY Sandoz Group	N/A
TEVA Teva Pharmaceutical Industries	0.54%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
ORINY Orion OYJ	4,029	282.27 million	N/A	Not Optionable
OTSKY Otsuka	37,758	1.07 billion	N/A	Not Optionable
SDZNY Sandoz Group	23,567	440.00 million	N/A	Not Optionable
TEVA Teva Pharmaceutical Industries	33,950	1.17 billion	1.16 billion	Optionable

ORINY, OTSKY, TEVA, and SDZNY Headlines

Recent News About These Companies

Teva Pharmaceutical Industries (NYSE:TEVA) Stock Price Expected to Rise, Barclays Analyst Says

August 14 at 1:48 AM | americanbankingnews.com

Teva Pharmaceutical Industries (NYSE:TEVA) Sets New 1-Year High After Analyst Upgrade

August 13 at 10:39 AM | marketbeat.com

Humana agrees not to reference Teva's Israel ties at US drug trial

August 13 at 10:16 AM | reuters.com

Teva Pharmaceutical Industries Ltd: Moody's Ratings Upgrades Teva to Investment Grade, Reflecting the Ongoing Execution of Pivot to Growth Strategy

August 13 at 7:02 AM | finanznachrichten.de

ADAMA Appoints Orly Pascal as Chief Human Resources Officer

August 13 at 7:02 AM | finance.yahoo.com

AMRX Stock Surges 44.8% in 3 Months: Can the Rally Keep Running Now?

August 12 at 5:45 PM | finance.yahoo.com

Is AMRX Stock a Buy as Growth Improves but Execution Risks Persist?

August 12 at 5:45 PM | finance.yahoo.com

Can Amneal's Kashiv Deal Turn Biosimilars Into a Major Growth Engine?

August 12 at 5:45 PM | finance.yahoo.com

Teva Pharmaceutical Industries (NYSE:TEVA) Price Target Raised to $42.00

August 12 at 8:47 AM | marketbeat.com

Moody’s Ratings Upgrades Teva to Investment Grade, Reflecting the Ongoing Execution of Pivot to Growth Strategy

August 12 at 7:44 AM | theglobeandmail.com

Pacer Advisors Inc. Sells 484,736 Shares of Teva Pharmaceutical Industries Ltd. $TEVA

August 12 at 4:55 AM | marketbeat.com

Moody’s Ratings Upgrades Teva to Investment Grade, Reflecting the Ongoing Execution of Pivot to Growth Strategy

August 11 at 12:58 PM | finance.yahoo.com

Teva Pharmaceutical Industries Ltd. Receives Moody’s Upgrade to Investment-Grade Baa3 Rating

August 11 at 8:31 AM | quiverquant.comQ

Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) Given Average Rating of "Moderate Buy" by Brokerages

August 11 at 4:28 AM | marketbeat.com

Empowered Funds LLC Increases Holdings in Teva Pharmaceutical Industries Ltd. $TEVA

August 9, 2026 | marketbeat.com

Assenagon Asset Management S.A. Grows Position in Teva Pharmaceutical Industries Ltd. $TEVA

August 8, 2026 | marketbeat.com

Teva (TEVA) Q2 2026 Earnings Call Transcript

August 7, 2026 | fool.com

SUPN vs. TEVA: Which Stock Should Value Investors Buy Now?

August 7, 2026 | finance.yahoo.com

SUPN vs. TEVA: Which Stock Should Value Investors Buy Now?

August 7, 2026 | zacks.com

Bank of America Corp DE Has $119.24 Million Stock Holdings in Teva Pharmaceutical Industries Ltd. $TEVA

August 7, 2026 | marketbeat.com

Arrowstreet Capital Limited Partnership Reduces Stock Holdings in Teva Pharmaceutical Industries Ltd. $TEVA

August 7, 2026 | marketbeat.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

ORINY, OTSKY, TEVA, and SDZNY Company Descriptions

Orion OYJ OTCMKTS:ORINY

$43.02 0.00 (0.00%)

As of 08/13/2026

Orion Oyj develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) in Finland, Scandinavia, rest of Europe, North America, and internationally. The company provides prescription drugs and self-care products, which includes Nubeqa for the treatment of prostate cancer; Precedex, Dexdor, and Precedex for human use; Burana for inflammatory pain; Divina series for menopausal symptoms; Trexan for rheumatoid arthritis and cancer; Stalevo, Entacapone, and Comtess/Comtan for Parkinson's disease; Biosimilars for rheumatoid arthritis and inflammatory bowel diseases; and Simdax for acute decompensated heart failure, as well as Fareston for breast cancer. It also offers Salmeterol/fluticasone Easyhaler, Budesonide/formoterol Easyhaler, Formoterol Easyhaler, Budesonide Easyhaler, Beclomet Easyhaler, and Buventol Easyhaler drugs for the treatment of asthma and chronic obstructive pulmonary disease. In addition, the company provides veterinary drugs comprising Bonqat, Clevor, Domosedan, Domitor, Antisedan, Dexdomitor, Domosedan Gel, Sileo, and Tessie; APIs for generic compounds and proprietary products, as well as contract manufacturing services; and markets and sells veterinary drugs manufactured by other international companies. Further, the company has partnership with Propeller Health to connect the Easyhaler(R) product portfolio; and a research collaboration and license agreement with Amneal Pharmaceuticals, Inc. to commercialize Amneal's generic products. Orion Oyj was founded in 1917 and is headquartered in Espoo, Finland.

Otsuka OTCMKTS:OTSKY

$37.62 -1.43 (-3.65%)

As of 03:59 PM Eastern

Otsuka Holdings Co., Ltd. engages in the pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide. The company develops pharmaceutical products in the fields of psychiatry, neurology, oncology, cardiovascular and renal system, digestive system, ophthalmology, and diagnostics, as well as intravenous solutions and medical devices. It also provides clinical testing, medical equipment, food products, cosmetics, functional food products, chemical products, soft drinks, beverages, analytical and measurement instruments, nutritional products, vehicle headlight testers, synthetic resin molded products, paper products, and insecticide and toiletry products. In addition, the company offers IT solution services; adhesive tapes; flaky titanate and compounds; IV solutions; infusion and clinical nutrition products; hydrazine; plant-based food products; reinsurance underwriting services; wine; stable isotopes; food supplements; urinary tract health products; software and services for management of mental healthcare systems; anticancer drugs; terracess; bio-pesticides; dietetic food products; spring and mineral water; and polyolefin foams. Further, it engages in the warehousing and transport, medical device operational management, shared service, environmental health management, and venture capital and incubation businesses; rental of medical devices and related products; purchase and sale of agricultural products; import and export trading business; tuberculosis research and development activities; manufacturing and development of xenotransplantation products; and processing and marketing of functional films, as well as planning, design, production, and construction of ceramic boards and arts, ceramic walls, reliefs, terracotta, ceramic OT and portraits, and ceramic sign boards; and operation of travel agency, and Hotel Ridge and California Table. Otsuka Holdings Co., Ltd. was founded in 1921 and is headquartered in Tokyo, Japan.

Sandoz Group OTCMKTS:SDZNY

$89.81 -0.85 (-0.94%)

As of 03:50 PM Eastern

Sandoz Group AG develops, manufactures, and markets generic pharmaceuticals and biosimilars worldwide. The company covers therapeutic areas, including cardiovascular, central nervous system, oncology, infectious diseases, pain and respiratory, diabetes, immunology, endocrinology, hematology, and ophthalmology, as well as bone disease. It also provides a portfolio of active pharmaceutical ingredients and finished dosage forms. The company was founded in 1886 and is headquartered in Basel, Switzerland.

Teva Pharmaceutical Industries NYSE:TEVA

$36.78 +0.27 (+0.73%)

Closing price 03:59 PM Eastern

Extended Trading

$36.42 -0.37 (-0.99%)

As of 08:00 PM Eastern

Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, Israel, and internationally. It offers generic medicines in various dosage forms, such as tablets, capsules, injectables, inhalants, liquids, transdermal patches, ointments, and creams; sterile products, hormones, high-potency drugs, and cytotoxic substances in parenteral and solid dosage forms; and generic products with medical devices and combination products. The company focuses on the central nervous system (CNS), respiratory, and oncology areas. It provides active pharmaceutical ingredients, as well as contract manufacturing services; and operates an out-licensing platform that offers a portfolio of products to other pharmaceutical companies. The company also offers BENDEKA and TREANDA injections for the treatment of chronic lymphocytic leukemia and indolent b-cell non-hodgkin's lymphoma; GRANIX; TRISENOX; LONQUEX; and TEVAGRASTIM/RATIOGRASTIM. In addition, it provides COPAXONE for the treatment of relapsing forms of multiple sclerosis; AJOVY for the preventive treatment of migraine in adults; AUSTEDO for the treatment of neurodegenerative and movement disorders associated with Huntington's disease and tardive dyskinesia; UZEDY for the treatment of schizophrenia; ProAir RespiClick inhalation powder; QVAR for treatment for asthma; BRALTUS, a long-acting muscarinic antagonist; CINQAIR/CINQAERO injection; DuoResp Spiromax, an inhaled corticosteroid and long-acting beta-agonist bronchodilator; and AirDuo RespiClick fluticasone propionate and salmeterol inhalation powder. The company offers its OTC products under SUDOCREM, NasenDuo, DICLOX FORTE, OLFEN Max, and FLEGAMINA brand names. It has collaboration agreements with MedinCell; Sanofi; Alvotech; and Biolojic Design Ltd., as well as license agreement with MODAG GmbH. The company was founded in 1901 and is based in Tel Aviv, Israel.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest ORINY, OTSKY, TEVA, and SDZNY Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest ORINY, OTSKY, TEVA, and SDZNY Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

ORINY, OTSKY, TEVA, and SDZNY Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

ORINY, OTSKY, TEVA, and SDZNY Company Descriptions

Orion OYJ OTCMKTS:ORINY

Otsuka OTCMKTS:OTSKY

Sandoz Group OTCMKTS:SDZNY

Teva Pharmaceutical Industries NYSE:TEVA

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest ORINY, OTSKY, TEVA, and SDZNY Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest ORINY, OTSKY, TEVA, and SDZNY Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

ORINY, OTSKY, TEVA, and SDZNY Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

ORINY, OTSKY, TEVA, and SDZNY Company Descriptions

Orion OYJ OTCMKTS:ORINY

Otsuka OTCMKTS:OTSKY

Sandoz Group OTCMKTS:SDZNY

Teva Pharmaceutical Industries NYSE:TEVA

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools